Olygose   Report issue

For profit
Founded: Compiegne France (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2013
NCT02228746
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now